Document Detail

Effect of age on myocardial infarction and thrombolysis.
MedLine Citation:
PMID:  7893308     Owner:  NLM     Status:  MEDLINE    
Thrombolytic therapy has emerged as the treatment of choice for patients presenting with an acute myocardial infarction. Myocardial infarction is a major cause of morbidity and mortality in the elderly. Advancing age has been considered a relative contraindication to thrombolytic therapy despite the potential for the elderly to derive the greatest benefit from this therapy. This trend not to treat the elderly has been based on a perceived increased risk of complications. Available data pooled from several studies clearly show that the elderly benefit from thrombolytic therapy.
B Morgan; C L Emerman
Related Documents :
1951108 - Goals of thrombolytic therapy.
11994558 - Glycoprotein iib/iiia combination therapy in acute myocardial infarction: tailoring the...
7916228 - Do women with acute myocardial infarction receive the same treatment as men?
11213858 - A review of available fibrin-specific thrombolytic agents used in acute myocardial infa...
12169238 - Genetic basis for the origin of cardiac arrhythmias: implications for therapy.
24412188 - Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of emergency medicine     Volume:  13     ISSN:  0735-6757     ISO Abbreviation:  Am J Emerg Med     Publication Date:  1995 Mar 
Date Detail:
Created Date:  1995-04-27     Completed Date:  1995-04-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8309942     Medline TA:  Am J Emerg Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  196-8     Citation Subset:  IM    
Department of Emergency Medicine, MetroHealth Medical Center, Cleveland, OH 44109.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Trials as Topic
Middle Aged
Myocardial Infarction / drug therapy*,  physiopathology
Risk Factors
Thrombolytic Therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  9-1-1: rapid identification and treatment of acute myocardial infarction. National Heart Attack Aler...
Next Document:  Occupational fatality and persistent neurological sequelae after mass exposure to hydrogen sulfide.